Researcher.Life Logo

Annals of Dermatology : Impact Factor & More

eISSN: 2005-3894pISSN: 1013-9087

Key Metrics

CiteScore
1.4
Impact Factor
< 5
SJR
Q3Dermatology
SNIP
0.48
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Annals of Dermatology

Annals of Dermatology Journal Specifications

Overview
Publisher KOREAN DERMATOLOGICAL ASSOC
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1989
Website URLVisit website
View less

Planning to publish in Annals of Dermatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Annals of Dermatology

The SMAD-Pathway Mediates HMGB1-Induced Proliferation and Metastatic Progression in Cutaneous Squamous Cell Carcinoma Cells.
  • 1 Feb 2026
  • Annals of dermatology
Refining Nail Surgery: Clinical Pearls and Best Practices.
  • 1 Feb 2026
  • Annals of dermatology
Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study.
  • 1 Feb 2026
  • Annals of dermatology
Current Clinical Perspectives on Rosacea Management: Insights From a Korean Multicenter Expert Opinion Survey.
  • 1 Jan 2026
  • Annals of dermatology
TYRO3, AXL, MER (TAM) Receptor Expression in Korean Cutaneous Melanoma.
  • 1 Jan 2026
  • Annals of dermatology
The Potential Role of β-Asarone in Calcium Imbalance and Mitochondrial Dysfunction in Melanoma Cells.
  • 1 Jan 2026
  • Annals of dermatology
The SMAD-Pathway Mediates HMGB1-Induced Proliferation and Metastatic Progression in Cutaneous Squamous Cell Carcinoma Cells.
  • 1 Feb 2026
  • Annals of dermatology
Refining Nail Surgery: Clinical Pearls and Best Practices.
  • 1 Feb 2026
  • Annals of dermatology
Efficacy and Safety of Novel Botulinum Toxin Type A (Protoxin) in the Treatment of Moderate to Severe Glabellar Lines: A Multicenter, Randomized, Double-Blind, Active-Controlled Phase III Study.
  • 1 Feb 2026
  • Annals of dermatology
Current Clinical Perspectives on Rosacea Management: Insights From a Korean Multicenter Expert Opinion Survey.
  • 1 Jan 2026
  • Annals of dermatology
TYRO3, AXL, MER (TAM) Receptor Expression in Korean Cutaneous Melanoma.
  • 1 Jan 2026
  • Annals of dermatology
The Potential Role of β-Asarone in Calcium Imbalance and Mitochondrial Dysfunction in Melanoma Cells.
  • 1 Jan 2026
  • Annals of dermatology

FAQs on Annals of Dermatology